Ledger.Open graph →
SEC Form D · filed June 20, 2025

GeneCentric Therapeutics, Inc

Offering
$5.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Michael Milburn · Durham, NCExec · DirectorCharles Perou · Durham, NCDirectorMyla Lai-Goldman · Durham, NCDirectorArnold Levine · Durham, NCDirectorClay Thorp · Durham, NCDirectorMichael K. Perry · Brisbane, CADirectorDarshana K. Zaveri · Brisbane, CADirectorRyan K. Drant · Brisbane, CADirectorSameer Jafri · Brisbane, CAExec · DirectorChristopher K. Croddy · Brisbane, CADirectorPrasanth Reddy · Durham, NCDirectorDon Hardison · Boston, MADirectorLaurence J. Marton · Los Altos, CADirectorUna S. Ryan · Los Altos, CADirectorRobert S. Spiegel · Los Altos, CADirectorRamtin R. Agah · Los Altos, CADirectorShaun R. Bagai · Los Altos, CAExec · DirectorPrasanth Reddy · Durham, NCDirectorDon Hardison · Durham, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗